Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05385536 · ClinicalTrials.gov registry record
Evaluating UTI Outcomes in at Risk Populations
A clinical trial, sponsored by Pathnostics.
- Completed
- Registry status
- 7,921
- Enrollment target
NCT05385536: Completed study, sponsored by Pathnostics.
NCT05385536 is a clinical trial that has completed, run by Pathnostics. The registered enrollment target is 7,921 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05385536 has completed, sponsored by Pathnostics.
- COMPLETED
- Registry status
- 7,921 participants
- Enrollment target
Study Summary
This is a multicenter, observational comparative cohort, study to evaluate the UTI related adverse event rates between Guidance® UTI clinical pathway versus the current traditional clinical pathways for urine testing.
Primary Outcome
UTI-related ED visit and/or hospitalization within 30 days of index visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,921 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2024-03-29 |
What the finished NCT05385536 record still lists
NCT05385536 is an observational study that tracks outcomes without assigning an intervention. Its 7,921 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05385536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05385536 about?
NCT05385536 is a clinical study titled "Evaluating UTI Outcomes in at Risk Populations". This is a multicenter, observational comparative cohort, study to evaluate the UTI related adverse event rates between Guidance® UTI clinical pathway versus the current traditional clinical pathways for urine testing.
What is the current status of trial NCT05385536?
This trial is currently completed. The enrollment target is 7,921 participants. The study started on 2022-07-18. Estimated completion is 2024-03-29.
Who is sponsoring clinical trial NCT05385536?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI